Generic name: pancrelipase (oral route) [ AM-i-lase, LYE-pase, PROE-tee-ase ]
Drug class:Digestive enzymes
Medically reviewed by Drugs.com. Last updated on Apr 30, 2022.
Commonly used brand name(s)
In the U.S.
- Creon
- Palcaps
- Pancreaze
- Pancrelipase
- Pangestyme EC
- Panocaps
- Pertzye
- Ultracaps
- Ultresa
- Viokace
- Zenpep
In Canada
- Viokase
Available Dosage Forms:
- Tablet
- Capsule, Delayed Release
- Capsule
Therapeutic Class: Enzyme Replacement
Pharmacologic Class: Enzyme
Uses for Ultracaps
Pancrelipase is used to help improve food digestion in certain conditions (eg, cystic fibrosis, pancreatitis) where the pancreas is not working properly. Pancrelipase contains the enzymes (including lipases, proteases, and amylases) needed for the digestion of proteins, starches, and fats.
This medicine is available only with your doctor's prescription.
Before using Ultracaps
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of Creon®, Pancreaze®, Pertzye®, and Zenpep® in children.
Appropriate studies have not been performed on the relationship of age to the effects of Ultresa™ in children younger than 12 months of age, and Viokace™ in children. Safety and efficacy have not been established in these age groups.
Geriatric
No informa...
